Cargando…

Dose‐dependent effect of mesenchymal stromal cells co‐grafted with dopaminergic neurons in a Parkinson's disease rat model

A major limiting factor for cell therapy in Parkinson's disease is the poor survival and reinnervation capacity of grafted dopaminergic neurons, independently of the cell source. Mesenchymal stromal cells (MSCs) have high capability to regulate the local environment through the release of troph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez‐Pallares, Jannette, Garcia‐Garrote, Maria, Parga, Juan A., Labandeira‐Garcia, Jose Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505847/ https://www.ncbi.nlm.nih.gov/pubmed/34535974 http://dx.doi.org/10.1111/jcmm.16900

Ejemplares similares

Combined cell-based therapy strategies for the treatment of Parkinson’s disease: focus on mesenchymal stromal cells
por: Rodríguez-Pallares, Jannette, et al.
Publicado: (2022)

NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin
por: Parga, Juan A., et al.
Publicado: (2021)

Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines
por: Parga, Juan A., et al.
Publicado: (2018)

Brain renin-angiotensin system and dopaminergic cell vulnerability
por: Labandeira-García, Jose L., et al.
Publicado: (2014)

Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular–Subventricular Zone
por: Garcia-Garrote, Maria, et al.
Publicado: (2019)

Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene
por: Labandeira‐Garcia, Jose L., et al.
Publicado: (2022)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
por: Xu, Zhimin, et al.
Publicado: (2017)

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson’s disease
por: Zhao, Yi, et al.
Publicado: (2018)

NADPH-Oxidase, Rho-Kinase and Autophagy Mediate the (Pro)renin-Induced Pro-Inflammatory Microglial Response and Enhancement of Dopaminergic Neuron Death
por: Lopez-Lopez, Andrea, et al.
Publicado: (2021)

Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration
por: Diaz-Ruiz, Carmen, et al.
Publicado: (2015)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
por: Qarin, Shamma, et al.
Publicado: (2021)

The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons
por: Labandeira-Garcia, Jose L., et al.
Publicado: (2021)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
por: Fernández-Santiago, Rubén, et al.
Publicado: (2019)

Human Mesenchymal Stromal Cells Unveil an Unexpected Differentiation Potential toward the Dopaminergic Neuronal Lineage
por: Gaggi, Giulia, et al.
Publicado: (2020)

Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
por: Labandeira-Garcia, Jose L., et al.
Publicado: (2017)

Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging
por: Rodriguez-Perez, Ana I., et al.
Publicado: (2016)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
por: Rodriguez-Perez, Ana I., et al.
Publicado: (2018)

An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria
por: Valenzuela, Rita, et al.
Publicado: (2021)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Renin angiotensin system and gender differences in dopaminergic degeneration
por: Rodriguez-Perez, Ana I, et al.
Publicado: (2011)

Functional Integration of Grafted Neural Stem Cell-Derived Dopaminergic Neurons Monitored by Optogenetics in an In Vitro Parkinson Model
por: Tønnesen, Jan, et al.
Publicado: (2011)

The differentiation of human placenta-derived mesenchymal stem cells into dopaminergic cells in vitro
por: Chen, Li, et al.
Publicado: (2009)

Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques
por: Sucunza, Diego, et al.
Publicado: (2021)

Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease
por: Morales-Garcia, Jose A., et al.
Publicado: (2011)

Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson’s Disease
por: Peng, Su-Ping, et al.
Publicado: (2015)

Exercise Promotes Neurite Extensions from Grafted Dopaminergic Neurons in the Direction of the Dorsolateral Striatum in Parkinson’s Disease Model Rats
por: Torikoshi, Sadaharu, et al.
Publicado: (2020)

Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis
por: McNeill, Alisdair, et al.
Publicado: (2013)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis
por: Huang, Zifeng, et al.
Publicado: (2021)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
por: Morales, Ingrid, et al.
Publicado: (2021)

Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice
por: Treacy, Oliver, et al.
Publicado: (2021)

Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons
por: Wang, Danling, et al.
Publicado: (2008)

Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones
por: Beynon, Amy L, et al.
Publicado: (2013)

Differentiation of adult human mesenchymal stem cells into dopaminergic neurons
por: Khademizadeh, Marjan, et al.
Publicado: (2019)

Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson’s Disease
por: Gonzalez-Alcocer, Alfredo, et al.
Publicado: (2023)

Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
por: Wang, Ronglin, et al.
Publicado: (2018)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_brb6o3j9cf8cvcq85ee5j33vsj